“…α-Amyrin was the main product of IaAS1, and the ratio of α-amyrin to β-amyrin was about 4:1. β-Amyrin was the main product of IaAS2, and the ratio of α-amyrin to β-amyrin was about 1:19 [16]. Several site-directed mutations of other OSCs (AsAS: β-amyrin synthase of Avena strigose [18], AtCYC: Cycloartenol synthase of Arabidopsis thaliana [19], AtCBS: Cucurbitadienol synthase of Arabidopsis thaliana [20], AtCPI: Cyclopropylsterol-cycloisomerase of Arabidopsis thaliana [21], AtLSSl: Lanosterol synthase of Arabidopsis thaliana [22], AtLUP1: Lupeol synthase 1 of Arabidopsis thaliana [18], CcLSS: Lanosterol cyclase of Cephalosporium caerulens [23], EtAS: β-amyrin synthase of Euphorbia tirucalli [24,25,26,27], OeLS: Lupeol synthase of Olea europaea [28], PgAS: β-amyrin Synthase of Panax ginseng [28], and ScLSS: Lanosterol cyclase of Saccharomyces cerevisiae [29,30,31,32,33,34,35,36,37]) have been performed (Supplementary Table S1). Multi-sequence alignment of sequences of IaAS1, IaAS2, human lanosterol synthase and seven enzymes from plants (AsAS, AtCYC, AtLSS1, AtLUP1, EtAS, O2LS, PgAS) provides key information for identifying the interface of enzyme-substrate/intermediate/product interaction (Supplementary Figure S1).…”